TARS PEER ANALYSIS

Tarsus Pharmaceuticals Inc — metric-by-metric comparison with peers and the industry median

TARSTarsus Pharmaceuticals Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value it Duel

Overall Profile & Returns

· Biotechnology

Position Within Industry

0 = weak quartile, 100 = strong quartile

TARSIndustry median

Scores normalize each metric against industry quartiles (p25–p75); direction is inverted for lower-is-better metrics.

Return Comparison

1-Year

Split-adjusted

Year-to-Date (YTD)

Key Metric Comparison

P/E

Lower is better

ROE

Higher is better

Net Margin

Higher is better

Revenue Growth

Higher is better

All Metrics

Valuation
Metric	TARS	TLX	MSB	CSL	Ind. Median
P/E	—	—	—	30.02	17.81
P/B	8.25	6.56	—	2.24●	3.49
EV/EBITDA	—	123.31	—	10.37●	14.92
P/S	5.38	3.34	31.91	2.67●	10.89

Financial Health
Metric	TARS	TLX	MSB	CSL	Ind. Median
Current Ratio	3.74●	1.43	—	2.57	5.90
Debt/Equity	25.4%●	112.3%	—	67.4%	10.9%
NetDebt/EBITDA	7.47	13.13	—	2.22●	1.15

Profitability
Metric	TARS	TLX	MSB	CSL	Ind. Median
Net Margin	-9.0%	-0.9%	-115.3%	9.2%●	-125.7%
ROE	-14.0%	-1.8%	-11.3%	7.7%●	-47.5%
ROA	-8.9%	-0.7%	-8.6%	3.8%●	-35.8%
EBITDA Margin	-7.5%	3.0%	-76.6%	32.8%●	-105.8%

Growth + Dividend
Metric	TARS	TLX	MSB	CSL	Ind. Median
Rev. Growth	129.0%	56.3%	410.4%●	4.8%	5.1%
NI Growth	—	—	—	-39.4%	12.1%
Div. Yield	—	—	0.0%	2.5%●	0.2%
Payout	—	—	0.0%	103.1%	0.0%

Valuation
Metric	TARS	IRON	VERA	NRIX	TRVI	COGT	Ind. Median
P/E	—	—	—	—	—	—	17.81
P/B	8.25	4.31●	5.74	5.50	15.18	4.38	3.49
EV/EBITDA	—	—	—	—	—	—	14.92
P/S	5.38	-247.45●	—	36.86	—	—	10.89

Financial Health
Metric	TARS	IRON	VERA	NRIX	TRVI	COGT	Ind. Median
Current Ratio	3.74	24.00	13.64	6.01	24.75●	15.14	5.90
Debt/Equity	25.4%	4.5%	15.0%	12.2%	0.4%●	39.3%	10.9%
NetDebt/EBITDA	7.47	2.93	1.46●	1.76	3.76	1.79	1.15

Profitability
Metric	TARS	IRON	VERA	NRIX	TRVI	COGT	Ind. Median
Net Margin	-9.0%	2,016.9%●	—	-411.4%	—	—	-125.7%
ROE	-14.0%●	-35.8%	-71.3%	-61.4%	-33.6%	-85.7%	-47.5%
ROA	-8.9%●	-33.1%	-59.9%	-47.2%	-31.8%	-59.7%	-35.8%
EBITDA Margin	-7.5%	1,988.9%●	—	-382.1%	—	—	-105.8%

Growth + Dividend
Metric	TARS	IRON	VERA	NRIX	TRVI	COGT	Ind. Median
Rev. Growth	129.0%●	—	—	27.2%	-100.0%	-100.0%	5.1%
NI Growth	—	—	—	—	—	—	12.1%
Div. Yield	—	—	—	—	—	—	0.2%
Payout	—	—	—	—	—	—	0.0%

The green dot marks the best value in the group given the metric direction (higher/lower is better). All metrics use trailing-twelve-month (TTM) data.

Go deeper on TARS

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Jul 6, 26. This content is for informational purposes only and is not investment advice.